4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000099
Chief Medical Officer sold 20,407 shares at an average $27.28 ($556,671)
- Chief Medical Officer acquired 14,058 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-07-13 | Option exercise 10b5-1 | +3,542 | $10.20 | $36,128 | 61,275 | D |
| Rodman David Malcom Chief Medical Officer | 2026-07-13 | Option exercise 10b5-1 | +4,167 | $14.25 | $59,380 | 65,442 | D |
| Rodman David Malcom Chief Medical Officer | 2026-07-13 | Option exercise 10b5-1 | +6,349 | $1.08 | $6,857 | 71,791 | D |
| Rodman David Malcom Chief Medical Officer | 2026-07-13 | Sale 10b5-1 | −14,058 | $27.58 | $387,717 | 57,733 | D |
| Rodman David Malcom Chief Medical Officer | 2026-07-15 | Sale 10b5-1 | −6,349 | $26.61 | $168,955 | 51,384 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-07-13 | Option exercise · Stock Option 10b5-1 | −3,542 | 109,792 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-07-13 | Option exercise · Stock Option 10b5-1 | −4,167 | 79,167 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-07-13 | Option exercise · Stock Option 10b5-1 | −6,349 | 0 | D | ||
| Open-market sales · 20,407 sh · avg $27.28 · $556,671 | |||||||
Loading xslF345X06/wk-form4_1784163485.xml…